miR-4432 Targets FGFBP1 in Human Endothelial Cells

Author:

Avvisato Roberta123,Mone Pasquale12,Jankauskas Stanislovas S.12ORCID,Varzideh Fahimeh12,Kansakar Urna12ORCID,Gambardella Jessica123,De Luca Antonio4ORCID,Matarese Alessandro5,Santulli Gaetano123678

Affiliation:

1. Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA

2. Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY 10461, USA

3. Department of Advanced Biomedical Sciences, “Federico II” University, 80131 Naples, Italy

4. Department of Mental and Physical Health and Preventive Medicine, University of Campania “Luigi Vanvitelli”, 81100 Caserta, Italy

5. “Antonio Cardarelli” Hospital, 80100 Naples, Italy

6. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, USA

7. Fleischer Institute for Diabetes and Metabolism (FIDAM), New York, NY 10461, USA

8. Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York, NY 10461, USA

Abstract

MicroRNAs (miRs) are small non-coding RNAs that modulate the expression of several target genes. Fibroblast growth factor binding protein 1 (FGFBP1) has been associated with endothelial dysfunction at the level of the blood–brain barrier (BBB). However, the underlying mechanisms are mostly unknown and there are no studies investigating the relationship between miRs and FGFBP1. Thus, the overarching aim of the present study was to identify and validate which miR can specifically target FGFBP1 in human brain microvascular endothelial cells, which represent the best in vitro model of the BBB. We were able to identify and validate miR-4432 as a fundamental modulator of FGFBP1 and we demonstrated that miR-4432 significantly reduces mitochondrial oxidative stress, a well-established pathophysiological hallmark of hypertension.

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

the National Heart, Lung, and Blood Institute

the National Center for Advancing Translational Sciences

the Diabetes Action Research and Education Foundation

the Monique Weill Caulier and Irma T. Hirschl Trusts

the American Heart Association

Publisher

MDPI AG

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3